Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nassar El Assaad

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Public Health|May 1, 2026
Impact of the late Syrian crisis on infectious diseases in Lebanon: a systematic reviewAkel Azzi, Nassar El Assaad, Joe Lebbos, et al.
JCO Global Oncology|January 28, 2026
Cancer Care in Crisis: How Subsidy Cuts Affected Immunotherapy Access for Patients With Small Cell Lung Cancer in LebanonNassar El Assaad, Muriel Slim, Joumana Yeretzian, et al.
Disaster Medicine and Public Health Preparedness|June 13, 2025
Healing Under Fire: The Challenges Facing Lebanon's Health Care Amid WarAkel Azzi, Nassar El Assaad, Elie Haddad, et al.
Cancers|January 28, 2026
First-Line Chemotherapy Regimens for Advanced and Metastatic Leiomyosarcoma: Doxorubicin vs. Gemcitabine-A Systematic ReviewIlma Khan, Priyal Agarwal, Nassar El Assaad, et al.
IJID Regions|July 24, 2025
Febrile neutropenia in the Middle East and North Africa Region: trends, management, and outcomes (2000-2024)-A systematic reviewNassar El Assaad, Akel Azzi, Francois Haddad, et al.
World Journal of Experimental Medicine|September 23, 2024
Anti-aging based on stem cell therapy: A scoping reviewNassar El Assaad, Alain Chebly, Rawad Salame, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Public Health|May 1, 2026
Impact of the late Syrian crisis on infectious diseases in Lebanon: a systematic reviewAkel Azzi, Nassar El Assaad, Joe Lebbos, et al.
JCO Global Oncology|January 28, 2026
Cancer Care in Crisis: How Subsidy Cuts Affected Immunotherapy Access for Patients With Small Cell Lung Cancer in LebanonNassar El Assaad, Muriel Slim, Joumana Yeretzian, et al.
Disaster Medicine and Public Health Preparedness|June 13, 2025
Healing Under Fire: The Challenges Facing Lebanon's Health Care Amid WarAkel Azzi, Nassar El Assaad, Elie Haddad, et al.
Cancers|January 28, 2026
First-Line Chemotherapy Regimens for Advanced and Metastatic Leiomyosarcoma: Doxorubicin vs. Gemcitabine-A Systematic ReviewIlma Khan, Priyal Agarwal, Nassar El Assaad, et al.
IJID Regions|July 24, 2025
Febrile neutropenia in the Middle East and North Africa Region: trends, management, and outcomes (2000-2024)-A systematic reviewNassar El Assaad, Akel Azzi, Francois Haddad, et al.
World Journal of Experimental Medicine|September 23, 2024
Anti-aging based on stem cell therapy: A scoping reviewNassar El Assaad, Alain Chebly, Rawad Salame, et al.
Pageof 1